A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.
Advanced gastrointestinal cancer patients with weight loss and an acute-phase response (n = 15) were given megestrol acetate (480 mg day(-1)) and ibuprofen (1200 mg day(-1)) for 6 weeks. Overall, there was an increase in body weight (P = 0.01) and a reduction in C-reactive protein concentrations (P...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
1997
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228041/ |